Mouse Immunopathology

申请人寻求对职业中期研究者进行密集小鼠免疫病理学的支持 使用比较病理学方法进行研究，并指导小鼠病理生物学的初级研究人员 research.刘晨博士是一位经过委员会认证的外科病理学家。他是一名副教授， 胃肠道和肝脏病理学服务，以及GI/肝脏病理学奖学金培训主任 程序.刘博士积极从事临床病人护理，基础和转化研究使用moue 模型，并指导临床研究员，居民，博士后研究员，研究生， 本科生。刘博士的主要研究重点是丙型肝炎病毒感染的免疫病理学， 目前由NIH赠款。他的团队已经建立了新的小鼠模型来研究 病毒感染的免疫反应。在这项提案中，他将研究T细胞的反应和功能， 调节性T细胞在HCV感染中的作用他将测试新的策略，利用免疫反应， HCV感染。刘博士的研究小组由非常有才华的年轻博士后研究员组成， 研究生、住院医生/实习医生、医学生和本科生。目标是指导 开始的研究人员成为未来的研究人员，他们拥有小鼠和人类的专业知识， 免疫病理学此外，刘博士还建立了国际合作， 免疫病理学研究通过这些研究，刘博士确立了自己作为专家的地位， 比较小鼠免疫病理学在过去的8年里，刘博士共同撰写了63篇同行评审的论文， 文章和9本书的章节/评论。在研究所内，刘医生是一位知名的病理学家， 在人类和小鼠系统的专业知识。他参与了自身免疫性疾病的研究项目 使用小鼠模型。由于这些广泛的正在进行的研究活动，刘博士打算 专门的时间来培训新的研究人员，他们将填补生物医学领域对小鼠病理学家日益增长的需求。 research.佛罗里达大学有一个全面的动物护理设施，169,026平方英尺的 太空中有超过350种小鼠和1，400种经批准的研究方案。与附加 通过与当地和全国的合作，该机构将为刘博士的研究提供一个出色的环境。 职业发展和指导下一代小鼠病理生物学家。K26职业生涯中期奖是 一个很好的机制来支持刘博士实现这一目标。 相关性（参见说明）： 丙型肝炎病毒是一种主要的人类传染病，目前尚无预防性疫苗。本研究将调查 使用小鼠模型进行免疫反应，这将有助于开发新的疫苗。通过这项研究， 研究者将指导年轻的研究者进行小鼠病理生物学研究。

The applicant seeks support for a midcareer investigator to conduct intensive mouse immunopathology research using comparative pathology approach and to mentor beginning investigators in mouse pathbiology research. Dr. Chen Liu is a board-certified surgical pathologist. He is an Associate Professor, the Director of Gastrointestinal and Liver Pathology Service, and the Director of GI/Liver Pathology Fellowship training program. Dr .Liu is actively engaged in clinical patient care, basic and translational research using moue models, and mentoring clinical fellows, residents, postdoctoral fellows, graduate students, and undergraduate students. Dr. Liu's primary research focus is immunopathology of hepatitis C viral infection, which is currently supported by NIH grants. His team has established novel mouse models to investigate immune responses in viral infection. In this proposal, he will study the T cell response and the function of regulatory T cells in HCV infection. He will test novel strategies to harness the immune response against HCV infection. Dr. Liu's research group consists of very talented young postdoctoral research fellows, graduate students, residents/follows, medical student, and undergraduate student. The goal is to mentor beginning investigators to become future investigators who have the expertise in both mouse and human immunopathology. In addition, Dr. Liu has established international collaborations on mouse immuopathology research. Through these studies, Dr. Liu has established himself as an expert in comparative mouse immunopathology. Over the past 8 years, Dr. Liu has co-authored 63 peer-reviewed articles and 9 book chapters/reviews. Within the Institution, Dr. Liu is a well-established pathologist who has expertise in both human and mouse systems. He is involved in research projects on autoimmune diseases using mouse models. Because of these extensive ongoing research activities, Dr. Liu intends to have dedicated time to train new investigators who will fill the growing need of mouse pathologist in biomedical research. The University of Florida has a comprehensive animal care facility with 169,026 square feet of space that hosts more than 350 strains of mice and 1,400 approved research protocols. With additional collaborations locally and nationally, the institution will provide an outstanding environment for Dr. Liu's career development and mentoring next generation of mouse pathobiologists. The K26 midcareer award is an excellent mechanism to support Dr. Liu to achieve this goal. RELEVANCE (See instructions): ' Hepatitis C virus is a major human infectious disease without preventive vaccine. This study will investigate the immune responses using a mouse model, which will help develop novel vaccines. Through this study, the investigator will mentor young investigators for mouse pathobioplogy study.